← Eichor
Study identifier: NCT07403825 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

Condition: Macular Degeneration, Age Related  ·  Sponsor: Biobizkaia Health Research Institute

PhasePhase 4
Planned participants100
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

Whose aim is to: Determine the percentage of patients with resolution of subretinal hyperreflective material (SHRM) at week 16. This study is intended to be performed in the ophthalmology departments or ophthalmology clinics of the participating sites, located in Spain. Macular degeneration is an eye disease characterised by progressive damage to the macula leading to a loss of central vision. There are two types of macular degeneration, dry and wet or exudative. The prevalence of the latter in Spain is 1.9% in people aged 65 and over. Among the subtypes of macular neovascularisation (MNV), type 2 is rare (9%), with the majority being mixed type 1 and 2 cases (13.5%). SHRM is present in about 77% of eyes with neovascular age-related macular degeneration (AMD). Different anti-VEGF (vascular endothelial growth factor) drugs have been used for the treatment of type 2 and mixed 1 and 2 types of MNV. Following treatment, a reduction in SHRM has been observed, although results between studies vary between 34% and 56%. Improvements in best-corrected visual acuity are also achieved in eyes with type 2 MNV with anti-VEGF therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (10)

Hospital ArruzafaCórdoba, Andalusia, SpainRecruiting
Hospital Universitario BasurtoBilbao, Bizkaia, SpainRecruiting
Hospital Clínico Universitario de ValladolidValladolid, Castille and León, SpainRecruiting
Hospital Universitario Nuestra Señora del Perpétuo SocorroAlbacete, Castille-La Mancha, SpainRecruiting
Clinica BarraquerBarcelona, Catalonia, SpainRecruiting
Hospital Clínico San CarlosMadrid, Madrid, SpainRecruiting
Hospital Puerta de Hierro MajadahondaMajadahonda, Madrid, SpainRecruiting
Instituto Oftalmologico Fernandez-VegaOviedo, Principality of Asturias, SpainRecruiting
Oftalvist ValenciaBurjassot, Valencia, SpainRecruiting
Hospital General Universitario ValenciaValencia, Valencia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07403825